iRhythm Technologies (NASDAQ:IRTC – Get Free Report) will be issuing its quarterly earnings data after the market closes on Thursday, August 1st. Analysts expect the company to announce earnings of ($0.92) per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.
iRhythm Technologies (NASDAQ:IRTC – Get Free Report) last announced its earnings results on Thursday, May 2nd. The company reported ($1.47) EPS for the quarter, missing analysts’ consensus estimates of ($0.99) by ($0.48). iRhythm Technologies had a negative net margin of 25.33% and a negative return on equity of 69.87%. The firm had revenue of $131.93 million for the quarter, compared to analyst estimates of $128.87 million. On average, analysts expect iRhythm Technologies to post $-3 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
iRhythm Technologies Price Performance
Shares of iRhythm Technologies stock opened at $88.57 on Tuesday. The business has a 50 day simple moving average of $95.73 and a two-hundred day simple moving average of $105.74. iRhythm Technologies has a 12 month low of $70.24 and a 12 month high of $124.11. The stock has a market capitalization of $2.75 billion, a P/E ratio of -20.94 and a beta of 1.24. The company has a debt-to-equity ratio of 7.13, a current ratio of 7.10 and a quick ratio of 6.95.
Insider Activity
Analyst Upgrades and Downgrades
IRTC has been the subject of a number of research analyst reports. Morgan Stanley reduced their target price on iRhythm Technologies from $135.00 to $130.00 and set an “overweight” rating for the company in a report on Monday, July 15th. Wolfe Research raised iRhythm Technologies from a “peer perform” rating to an “outperform” rating and set a $115.00 target price for the company in a report on Thursday, June 20th. Canaccord Genuity Group reduced their target price on iRhythm Technologies from $133.00 to $122.00 and set a “buy” rating for the company in a report on Friday, May 3rd. Needham & Company LLC increased their target price on iRhythm Technologies from $137.00 to $138.00 and gave the company a “buy” rating in a report on Friday, May 3rd. Finally, Truist Financial dropped their price target on iRhythm Technologies from $145.00 to $134.00 and set a “buy” rating for the company in a research report on Tuesday, July 16th. One equities research analyst has rated the stock with a sell rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $130.88.
View Our Latest Analysis on IRTC
iRhythm Technologies Company Profile
iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.
Further Reading
- Five stocks we like better than iRhythm Technologies
- Investing in Travel Stocks Benefits
- Has Micron’s Stock Drop Turned Into A Screaming Buy?
- What is a Bond Market Holiday? How to Invest and Trade
- Should You Invest in Bonds? Here’s What to Know
- Manufacturing Stocks Investing
- Why This Manufacturer is Committing to a Massive Buyback Program
Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.